Literature DB >> 25548403

Patients' physical response to thiopental and alternative anesthetic agents in the setting of electroconvulsive therapy.

Kayleigh Gordon1, Donna M M Woloschuk2, Ashley N Walus3.   

Abstract

Entities:  

Year:  2014        PMID： 25548403      PMCID： PMC4275142          DOI： 10.4212/cjhp.v67i6.1408

Source DB:  PubMed          Journal:  Can J Hosp Pharm        ISSN： 0008-4123


× No keyword cloud information.
  13 in total

Review 1.  Electroconvulsive therapy: a selected review.

Authors:  Robert M Greenberg; Charles H Kellner
Journal:  Am J Geriatr Psychiatry       Date:  2005-04       Impact factor: 4.105

2.  Intranasal sumatriptan for prevention of post-ECT headaches.

Authors:  Paul F White; Lisa Purdue; Michael Downing; Larry Thornton
Journal:  Headache       Date:  2006-04       Impact factor: 5.887

Review 3.  Effects of general anesthetic agents in adults receiving electroconvulsive therapy: a systematic review.

Authors:  W Michael Hooten; Keith G Rasmussen
Journal:  J ECT       Date:  2008-09       Impact factor: 3.635

4.  Effect of etomidate versus thiopental on major depressive disorder in electroconvulsive therapy, a randomized double-blind controlled clinical trial.

Authors:  Mohammad Hassan Abdollahi; Amir Izadi; Mohammad Reza Hajiesmaeili; Ahmad Ghanizadeh; Ghasem Dastjerdi; Habib Allah Hosseini; Mohammad Mehdi Ghiamat; Hamid Reza Abbasi
Journal:  J ECT       Date:  2012-03       Impact factor: 3.635

5.  Benzodiazepines and Electroconvulsive Therapy.

Authors:  Robert M. Greenberg; Helen M. Pettinati
Journal:  Convuls Ther       Date:  1993

6.  Sumatriptan prophylaxis for postelectroconvulsive therapy headaches.

Authors:  C DeBattista; K Mueller
Journal:  Headache       Date:  1995-09       Impact factor: 5.887

7.  The course of myalgia and headache after electroconvulsive therapy.

Authors:  Stephen H Dinwiddie; Dezheng Huo; Ori Gottlieb
Journal:  J ECT       Date:  2010-06       Impact factor: 3.635

Review 8.  Electroconvulsive therapy: Part I. A perspective on the evolution and current practice of ECT.

Authors:  Nancy A Payne; Joan Prudic
Journal:  J Psychiatr Pract       Date:  2009-09       Impact factor: 1.325

9.  The influence of anaesthetic medication on safety, tolerability and clinical effectiveness of electroconvulsive therapy.

Authors:  Daniela Eser; Caroline Nothdurfter; Cornelius Schüle; Julia Damm; Yvonne Steng; Hans-Jürgen Möller; Rainer Rupprecht; Thomas Baghai
Journal:  World J Biol Psychiatry       Date:  2010-03       Impact factor: 4.132

10.  Relationships between seizure duration and seizure threshold and stimulus dosage at electroconvulsive therapy: implications for electroconvulsive therapy practice.

Authors:  Ka-Fai Chung
Journal:  Psychiatry Clin Neurosci       Date:  2002-10       Impact factor: 5.188
View more
  2 in total

1.  The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT).

Authors:  Mohammad Haghighi; Abbas Sedighinejad; Bahram Naderi Nabi; Cyrus Emiralavi; Gelareh Biazar; Kaveh Mirmozaffari; Cyrus Zahedan; Mehdi Jafari
Journal:  Anesth Pain Med       Date:  2016-03-27

2.  Medication management during electroconvulsant therapy.

Authors:  Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2016-04-19       Impact factor: 2.570
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.